nizatidine has been researched along with Gastroesophageal Reflux in 24 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 9 (37.50) | 18.2507 |
2000's | 12 (50.00) | 29.6817 |
2010's | 3 (12.50) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Haag, S; Holtmann, G | 1 |
Doyle, RT; Goetsch, AC; Griffin, C; Hejazi, RA; McCallum, RW; Rotenberg, K; Sarosiek, I; Zarling, EJ | 1 |
Futagami, S; Hoshihara, Y; Iwakiri, K; Kawami, N; Sakamoto, C; Sano, H; Tanaka, Y; Umezawa, M | 1 |
Bochenek, W; DeVault, K; Kovacs, TO; Miska, D; Wilcox, CM | 1 |
Armstrong, D; Goeree, R; Meyer, F; Paré, P; Pericak, D; Pyzyk, M | 1 |
Armstrong, D; Paré, P; Pericak, D; Pyzyk, M | 2 |
Herszényi, L | 1 |
Abdel-Rahman, SM; Connor, JD; Dupont, C; Gauthier-Dubois, G; Johnson, FK; Kearns, GL; Staiano, A; Tolia, V; Winter, H | 1 |
Bochenek, WJ; Fraga, PD; Mack, ME; Metz, DC | 1 |
Gremse, DA; Kling, DF; Orenstein, SR; Pantaleon, CD; Rotenberg, KS | 1 |
Castell, DO; Just, RJ; Lagerström, PO; Leite, LP | 1 |
Cloud, ML; Offen, WW; Robinson, M | 2 |
Cloud, ML; Offen, WW | 2 |
Berstad, A; Hatlebakk, JG | 1 |
Zarling, EJ | 1 |
Breslin, AB; Ing, AJ; Ngu, MC | 1 |
Grandidier, S; Loppinet, V; Moneret-Vautrin, DA; Morisset, M | 1 |
Kurosawa, S | 1 |
Etchason, J; Fultz, SL; Good, CB; Trilli, L | 1 |
Michocki, RJ; Richardson, JP | 1 |
7 review(s) available for nizatidine and Gastroesophageal Reflux
Article | Year |
---|---|
Onset of relief of symptoms of gastroesophageal reflux disease: post hoc analysis of two previously published studies comparing pantoprazole 20 mg once daily with nizatidine or ranitidine 150 mg twice daily.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Drug Administration Schedule; Drug Therapy, Combination; Female; Gastroesophageal Reflux; Humans; Male; Multicenter Studies as Topic; Nizatidine; Pantoprazole; Randomized Controlled Trials as Topic; Ranitidine | 2010 |
[Treatment of gastroesophageal reflux disease].
Topics: Anti-Ulcer Agents; Famotidine; Gastroesophageal Reflux; Histamine H2 Antagonists; Humans; Life Style; Nizatidine; Ranitidine | 2003 |
Pantoprazole provides rapid and sustained symptomatic relief in patients treated for erosive oesophagitis.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Antacids; Anti-Ulcer Agents; Benzimidazoles; Double-Blind Method; Esophagitis; Female; Gastroesophageal Reflux; Heartburn; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Male; Middle Aged; Nizatidine; Omeprazole; Pantoprazole; Randomized Controlled Trials as Topic; Sulfoxides; Treatment Outcome | 2004 |
Pharmacokinetic optimisation in the treatment of gastro-oesophageal reflux disease.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Antacids; Benzimidazoles; Cimetidine; Cisapride; Domperidone; Famotidine; Gastroesophageal Reflux; Histamine H2 Antagonists; Humans; Lansoprazole; Metoclopramide; Nizatidine; Omeprazole; Pantoprazole; Piperidines; Proton Pump Inhibitors; Ranitidine; Sucralfate; Sulfoxides | 1996 |
Prokinetic activity of nizatidine: implications for the management of patients with gastroesophageal reflux disease.
Topics: Anti-Ulcer Agents; Esophageal Motility Disorders; Gastroesophageal Reflux; Humans; Nizatidine | 1999 |
[Maintenance therapy of mild form of GERD by H2 receptor antagonists].
Topics: Aged; Gastroesophageal Reflux; Histamine H2 Antagonists; Humans; Male; Nizatidine | 2000 |
The clinical use of histamine-2 receptor antagonists.
Topics: Cimetidine; Drug Evaluation; Famotidine; Gastroesophageal Reflux; Humans; Nizatidine; Peptic Ulcer; Ranitidine; Recurrence; Time Factors | 1992 |
13 trial(s) available for nizatidine and Gastroesophageal Reflux
Article | Year |
---|---|
Multicenter, double-blind, placebo-controlled crossover study to assess the acute prokinetic efficacy of nizatidine-controlled release (150 and 300 mg) in patients with gastroesophageal reflux disease.
Topics: Cross-Over Studies; Delayed-Action Preparations; Dose-Response Relationship, Drug; Double-Blind Method; Female; Gastric Emptying; Gastroesophageal Reflux; Histamine H2 Antagonists; Humans; Male; Nizatidine; Radionuclide Imaging; Technetium | 2010 |
The effects of nizatidine on transient lower esophageal sphincter relaxations (TLESRs) and acid reflux in healthy subjects.
Topics: Esophageal pH Monitoring; Esophagus; Gastroesophageal Reflux; Histamine Agonists; Humans; Muscle Relaxation; Muscle, Smooth; Nizatidine | 2011 |
Comparison of the efficacy of pantoprazole vs. nizatidine in the treatment of erosive oesophagitis: a randomized, active-controlled, double-blind study.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Anti-Ulcer Agents; Benzimidazoles; Dose-Response Relationship, Drug; Double-Blind Method; Enzyme Inhibitors; Esophagitis, Peptic; Female; Gastroesophageal Reflux; Humans; Male; Middle Aged; Nizatidine; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Severity of Illness Index; Sulfoxides; Treatment Outcome | 2002 |
Validation of the GSFQ, a self-administered symptom frequency questionnaire for patients with gastroesophageal reflux disease.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Anti-Ulcer Agents; Benzimidazoles; Canada; Double-Blind Method; Female; Gastroesophageal Reflux; Humans; Male; Middle Aged; Nizatidine; Omeprazole; Pantoprazole; Quality of Life; Reproducibility of Results; Self-Assessment; Severity of Illness Index; Sulfoxides; Surveys and Questionnaires; Treatment Outcome | 2003 |
Pantoprazole rapidly improves health-related quality of life in patients with heartburn: a prospective, randomized, double blind comparative study with nizatidine.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Ulcer Agents; Benzimidazoles; Double-Blind Method; Gastroesophageal Reflux; Health Status Indicators; Heartburn; Humans; Nizatidine; Omeprazole; Pantoprazole; Quality of Life; Sulfoxides; Treatment Outcome | 2003 |
Developmental pharmacokinetics and pharmacodynamics of nizatidine.
Topics: Administration, Oral; Adolescent; Adult; Area Under Curve; Biological Availability; Capsules; Child; Child, Preschool; Chromatography, High Pressure Liquid; Dose-Response Relationship, Drug; Female; Gastric Acidity Determination; Gastroesophageal Reflux; Histamine H2 Antagonists; Humans; Infant; Infant, Newborn; Injections, Intravenous; Male; Metabolic Clearance Rate; Middle Aged; Nizatidine; Treatment Outcome | 2004 |
Nizatidine for the treatment of pediatric gastroesophageal reflux symptoms: an open-label, multiple-dose, randomized, multicenter clinical trial in 210 children.
Topics: Adolescent; Adult; Capsules; Chemistry, Pharmaceutical; Child; Child, Preschool; Drug Administration Schedule; Drug Tolerance; Female; Gastroesophageal Reflux; Histamine H2 Antagonists; Humans; Infant; Infant, Newborn; Male; Nizatidine; Solutions | 2005 |
Nizatidine versus placebo in gastro-oesophageal reflux disease: a 12-week, multicentre, randomised, double-blind study.
Topics: Adult; Aged; Double-Blind Method; Drug Administration Schedule; Female; Gastroesophageal Reflux; Humans; Male; Middle Aged; Nizatidine | 1994 |
Nizatidine versus placebo in gastro-oesophageal reflux disease: a 6-week, multicentre, randomised, double-blind comparison. Nizatidine Gastroesophageal Reflux Disease Study Group.
Topics: Adult; Aged; Double-Blind Method; Drug Administration Schedule; Esophagitis; Female; Gastroesophageal Reflux; Humans; Male; Middle Aged; Nizatidine; Treatment Outcome | 1994 |
Obstructive sleep apnea and gastroesophageal reflux.
Topics: Aged; Case-Control Studies; Female; Gastroesophageal Reflux; Histamine H2 Antagonists; Humans; Hydrogen-Ion Concentration; Male; Middle Aged; Monitoring, Physiologic; Nizatidine; Polysomnography; Sleep Apnea, Obstructive; Treatment Outcome | 2000 |
Symptom relief in gastroesophageal reflux disease: a randomized, controlled comparison of pantoprazole and nizatidine in a mixed patient population with erosive esophagitis or endoscopy-negative reflux disease.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Ulcer Agents; Benzimidazoles; Double-Blind Method; Enzyme Inhibitors; Esophagitis, Peptic; Esophagoscopy; Female; Gastroesophageal Reflux; Histamine H2 Antagonists; Humans; Male; Middle Aged; Nizatidine; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Sulfoxides | 2001 |
Nizatidine versus placebo in gastroesophageal reflux disease. A six-week, multicenter, randomized, double-blind comparison. Nizatidine Gastroesophageal Reflux Disease Study Group.
Topics: Double-Blind Method; Esophagitis, Peptic; Esophagoscopy; Female; Gastroesophageal Reflux; Heartburn; Humans; Male; Middle Aged; Nizatidine; Time Factors; Wound Healing | 1992 |
Nizatidine versus placebo in gastroesophageal reflux disease: a 12-week, multicenter, randomized, double-blind study.
Topics: Analysis of Variance; Double-Blind Method; Female; Gastroesophageal Reflux; Heartburn; Humans; Male; Middle Aged; Nizatidine; Severity of Illness Index | 1991 |
4 other study(ies) available for nizatidine and Gastroesophageal Reflux
Article | Year |
---|---|
Control of gastric acid with high dose H2-receptor antagonists after omeprazole failure: report of two cases.
Topics: Adult; Anti-Ulcer Agents; Cimetidine; Drug Resistance; Female; Gastric Acid; Gastroesophageal Reflux; Histamine H2 Antagonists; Humans; Male; Nizatidine; Omeprazole | 1995 |
Nizatidine treatment of gastro-oesophageal reflux disease.
Topics: Gastroesophageal Reflux; Humans; Nizatidine | 1994 |
Cross-allergy to ranitidine and nizatidine.
Topics: Adult; Anti-Ulcer Agents; Cross Reactions; Drug Hypersensitivity; Famotidine; Gastroesophageal Reflux; Humans; Male; Nizatidine; Ranitidine; Skin Tests; Structure-Activity Relationship | 2000 |
Therapeutic substitution of cimetidine for nizatidine was not associated with an increase in healthcare utilization.
Topics: Aged; Cimetidine; Cost Savings; Drug Costs; Duodenal Ulcer; Formularies, Hospital as Topic; Gastroesophageal Reflux; Health Services Research; Histamine H2 Antagonists; Hospitals, Veterans; Humans; Male; Middle Aged; Nizatidine; Outpatient Clinics, Hospital; Pennsylvania; Retrospective Studies; Stomach Ulcer; Therapeutic Equivalency | 2000 |